Explore expert insights and educational material on CAR T-cell therapy and access up-to-date information on non-Hodgkin lymphoma (NHL). The Kite Medical Hub is a non-promotional website intended for healthcare professionals in the UK and Ireland, designed, built and funded by Kite, a Gilead Company.
Welcome to eRMM Tool an interactive training tool on the management of cytokine release syndrome and neurotoxicity in your YESCARTA® (axicabtagene ciloleucel) CAR T patients.
A CAR T patient avatar will take you on their treatment journey: from preparing your delivery centre, handling and administering treatment to managing any side effects promptly.
Upon completing a quiz at the end, you will be awarded an accredited CPD Certificate.
Additional monitoring required.
Latest podcastSee more podcasts
Patient Perspectives: Long-Term Psycho-Social Impact of CAR T Back in the Community
Mr Stephen Scowcroft discusses the work of Lymphoma Action in wellbeing and education in patients receiving CAR T therapy, including the key role it plays in facilitating the voice of patients affected by lymphoma and how to improve the system going forward.
This podcast is intended for UK & Ireland HCPs who have registered with this Kite-owned website; please do not copy or distribute any content.
Latest eventsSee more events
GIO-Med virtual event 2020
Explore highlights from this year’s Gilead Immuno-Oncology Medical Education (GIO-Med) virtual event, broadcast as a series of pre-recorded educational videos and podcasts.
Join leading experts featured in the field of immuno-oncology as they discuss managing patients with diffuse large B-cell lymphoma (DLBCL) in clinical practice.
CAR T, chimeric antigen receptor T-cell; DLBCL, diffuse large B-cell lymphoma; HCP, healthcare professional; KCH, King’s College Hospitals; NHL, non-Hodgkin lymphoma; UK, United Kingdom.
You are now leaving the Kite a Gilead Company, non-promotional website.
You are being directed to